Skip to main content

Kura Oncology, Inc.

KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422143

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Kura Oncology, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of KURA: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders18311820
Shares80.4M69682.1M+1.64M (+2.0%)
Value$530.9M$4.59K$473.6M−$57.3M (−10.8%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Kura Oncology, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to KURA in Q2 2025
InstitutionSharesValue% of portfolio
Sectoral Asset Management Inc323,572$1.87M1.23%
Apis Capital Advisors, LLC180,000$1.04M0.37%
State of Wisconsin Investment Board138,846$801.1K0.00%
Balyasny Asset Management LLC135,647$782.7K0.00%
Rangeley Capital, LLC116,000$669.3K0.84%
Los Angeles Capital Management LLC77,958$449.8K0.00%
Squarepoint Ops LLC64,705$373.3K0.00%
Alps Advisors Inc46,660$269.2K0.00%
EntryPoint Capital, LLC30,025$173.2K0.09%
Amundi26,950$156.6K0.00%
Stonepine Capital Management, LLC25,000$144.3K0.14%
Pale Fire Capital SE20,100$116.0K0.01%
Bridgefront Capital, LLC18,708$107.9K0.03%
Brevan Howard Capital Management LP13,929$80.4K0.00%
Two Sigma Securities, LLC11,873$68.5K0.01%
Virtu Financial LLC11,283$65.0K0.00%
Essential Partners LLC2,114$12.2K0.00%
Parallel Advisors, LLC641$3.70K0.00%
Clearstead Advisors, LLC398$2.30K0.00%
Raymond James Financial Inc314$1.81K0.00%
Federated Hermes, Inc.291$1.68K0.00%
Skopos Labs, Inc.268$1.55K0.00%
IFP Advisors, Inc239$1.38K0.00%
Family Legacy Financial Solutions, LLC100$5770.00%
Bare Financial Services, Inc88$5080.00%
Hughes Financial Services, LLC81$4880.00%
Kilter Group LLC40$2310.00%
CIBC Private Wealth Group, LLC9$520.00%
Capital Advisors, Ltd. LLC13$00.00%

Sold out (29)

Institutions that held Kura Oncology, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Not filed for Q2 2025 yet (1)

Institutions that held Kura Oncology, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KURA in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Lindbrook Capital, LLC696$4.59K